Key points are not available for this paper at this time.
Whether enalapril improves on captopril remains unknown; leaves open the need for comparative trials in hypertension and heart failure.
Captopril was introduced in 1981 as the first inhibitor of angiotensin-converting enzyme (ACE). 1,2 Now we have enalapril (Innovace - MSD) as well: it is intended for the treatment of hypertension and resistant heart failure. Is it an improvement over captopril?
No takes yet. Share an insight, caveat, or question.
A 1985 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: